Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia

• Published in: Journal of global antimicrobial resistance. Vol. 20; pp. 110 - 117
• Main Authors: Tan, Yen Ee, Chen, Sharon C.-A., Halliday, Catriona L.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.03.2020; Elsevier
• Subjects: Amikacin - pharmacology; Anti-Infective Agents - pharmacology; Australia; Drug Resistance, Bacterial; Epidemiological Monitoring; Humans; Imipenem - pharmacology; Laboratories; Medically relevant Nocardia; Microbial Sensitivity Tests; Nocardia - classification; Nocardia - drug effects; Nocardia - isolation & purification; Nocardia Infections - drug therapy; Nocardia Infections - microbiology; Respiratory System - microbiology; Species distribution; Susceptibility; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology; Australia; Medically relevant Nocardia; Species distribution; Australia; Susceptibility

•Overall, 9.3% of the tested Nocardia spp. isolates displayed sulfonamide resistance.•N. farcinica accounted for the highest number of sulfonamide-resistant strains.•59.3% of Nocardia were imipenem-resistant; high imipenem resistance in N. cyriacigeorgica is atypical to its drug pattern.•A high leve...